Akèy › Skleroz Amiotrofik Lateral › Washington
Etid klinik pou Skleroz Amiotrofik Lateral nan Washington
7 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Swedish Medical Center, Seattle
- University of Washington, Seattle
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Zydus US011, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07023835ASSESS ALL ALS Study
- University of Washington, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
- University of Washington, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- University of Washington, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04363684Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- University of Washington, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05137665Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.